This chapter reviews topics related to the demand for health insurance, including the
question of how choice of health insurance should be structured for consumers. After the first …

It is well known that pharmaceutical innovation has improved the health and quality of life of
patients. It is however sometimes forgotten that new drugs also have the potential of …

Researchers have disagreed about factors driving up health care spending since the 1980s.
One camp, led by Kenneth Thorpe, identifies rising numbers of people being treated for …

Objectives: The aim of this study was to develop and to assess a specific Multi-Criteria
Decision Analysis (MCDA) framework to evaluate new drugs in an hospital pharmacy and …

Effective chronic condition management is dependent upon prescription medication access
and compliance. Impacted access results in increased pain, worsening of the condition and …

Since efficacy in one or more preclinical animal tumor models generally provides the
rationale in support of a new antineoplastic drug's probable benefit in humans, is the primary …

Purpose: To compare medical expenditures of patients receiving old and new colorectal
cancer (CRC) regimens. Study Design: Using claims data, we identified two cohorts of …

The Role of Funding and Policies on Innovation in Cancer Drug Development - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Over the recent decades, advances in healthcare technology have led to significant
improvements in the quality of healthcare and in population health. At the same time …

In the debate over prescription drug pricing, some pharmaceutical industry critics claim that
US taxpayers pay twice for costly therapies, because publicly supported research is a major …